Abemaciclib in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma, and in Children With Recurrent and Refractory Solid Tumors Including Malignant Brain Tumors

Trial Profile

Abemaciclib in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma, and in Children With Recurrent and Refractory Solid Tumors Including Malignant Brain Tumors

Recruiting
Phase of Trial: Phase I

Latest Information Update: 19 Jul 2017

At a glance

  • Drugs Abemaciclib (Primary)
  • Indications Brain cancer; Ewing's sarcoma; Glioma; Neuroblastoma; Osteosarcoma; Rhabdoid tumour; Rhabdomyosarcoma; Solid tumours
  • Focus Adverse reactions; Pharmacokinetics
  • Acronyms AflacST1501
  • Most Recent Events

    • 09 Feb 2016 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
    • 08 Jan 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top